Optimizing CAR T-Cell Therapy in DLBCL With Community and Academic Perspectives - Episode 5
Experts discuss the main operational challenges faced in the community setting when it comes to chimeric antigen receptor T-cell therapy (CAR T) and the best practices implemented to mitigate these challenges.
Video content above is prompted by the following: